Skip to content
  • Facebook
  • Twitter
This translation is automatically provided by Google; please refer to the original English version for appropriate wording.
Take on Typhoid

Take on Typhoid

  • Home
  • Why Typhoid?
    • Typhoid & Related Salmonelloses
    • Global Research
    • Links & Resources
  • The Issues
    • Vaccines
    • WASH
    • Drug-Resistant Typhoid
    • Treatment
    • Diagnostics
    • Typhoid intestinal perforation
    • Related Issues
  • Resources & Tools
    • Talk About Typhoid
    • Global Policy
    • Country Tools
    • Infographics
    • Fact Sheets
    • TCV Cost-effectiveness
    • Share on Social
  • Blog & News
    • Blog
    • News
    • Publications
    • Newsletter
  • International Conference
    • Past Conferences
    • Conference Travel
  • About Us
    • About the Coalition against Typhoid
    • About the Typhoid Vaccine Acceleration Consortium

Gates Open Research page is now available!

Posted on January 8, 2025 by Lauren Radice

The TyVAC gateway showcases project-related research and provides open access to project publications. Please click “Learn More” to access the page.

learn more

Post navigation

Navigating change as we take on typhoid
Reaching 10 million children in Burkina Faso with TCVs

Related Posts

  • International Conference on Typhoid & Other Invasive Salmonelloses

  • Updated materials available!

Newsletter Signup

Recent Posts

  • The potential of typhoid conjugate vaccines to reduce antimicrobial use in Pakistan

  • Can glacier melt drive the spread of typhoid?

  • TCV: An early defense against typhoid in extreme weather conditions

  • Can better diagnostics improve typhoid prevention and treatment?

  • Réponse immunitaire robuste à la dose de rappel du vaccin antityphoïdique chez les enfants âgés de cinq ans au Malawi

cat
685 West Baltimore Street, Room 480
Baltimore, MD 21201-1509
Coalition against Typhoid
2175 K Street, NW, Suite 400
Washington, DC 20037
© 2018. Coalition Against Typhoid. All Rights Reserved.
  • Contact Us
  • Privacy Policy
  • Facebook
  • Twitter
Top